The RCGP curriculum mandates the capability to converse with patients about NHS screening programmes, as part of the objective to promote health and prevent disease. Over-diagnosis and over-treatment are the primary concerns associated with breast cancer screening. Research suggests that for every life saved by the screening programme, three women will receive treatment for a cancer that would not have posed a threat to their lives. Therefore, it is the woman’s personal decision to weigh the benefits against the risks when invited for routine screening.

Breast Cancer Screening and Familial Risk Factors

Breast cancer screening is offered to women aged 50-70 years through the NHS Breast Screening Programme, with mammograms offered every three years. While the effectiveness of breast screening is debated, it is estimated that the programme saves around 1,400 lives annually. Women over 70 years may still have mammograms but are encouraged to make their own appointments.

For those with familial risk factors, NICE guidelines recommend referral to a breast clinic for further assessment. Those with one first-degree or second-degree relative diagnosed with breast cancer do not need referral unless certain factors are present in the family history, such as early age of diagnosis, bilateral breast cancer, male breast cancer, ovarian cancer, Jewish ancestry, or complicated patterns of multiple cancers at a young age. Women with an increased risk of breast cancer due to family history may be offered screening from a younger age.

It is important to be aware of the role that hormones play during pregnancy.

Endocrine Changes During Pregnancy

During pregnancy, there are several physiological changes that occur in the body, including endocrine changes. Progesterone, which is produced by the fallopian tubes during the first two weeks of pregnancy, stimulates the secretion of nutrients required by the zygote/blastocyst. At six weeks, the placenta takes over the production of progesterone, which inhibits uterine contractions by decreasing sensitivity to oxytocin and inhibiting the production of prostaglandins. Progesterone also stimulates the development of lobules and alveoli.

Oestrogen, specifically oestriol, is another major hormone produced during pregnancy. It stimulates the growth of the myometrium and the ductal system of the breasts. Prolactin, which increases during pregnancy, initiates and maintains milk secretion of the mammary gland. It is essential for the expression of the mammotropic effects of oestrogen and progesterone. However, oestrogen and progesterone directly antagonize the stimulating effects of prolactin on milk synthesis.

Human chorionic gonadotropin (hCG) is secreted by the syncitiotrophoblast and can be detected within nine days of pregnancy. It mimics LH, rescuing the corpus luteum from degenerating and ensuring early oestrogen and progesterone secretion. It also stimulates the production of relaxin and may inhibit contractions induced by oxytocin. Other hormones produced during pregnancy include relaxin, which suppresses myometrial contractions and relaxes the pelvic ligaments and pubic symphysis, and human placental lactogen (hPL), which has lactogenic actions and enhances protein metabolism while antagonizing insulin.

During pregnancy, several physiological changes occur in the body. The tidal volume increases due to the relaxation of intercostal muscles and diaphragm caused by progesterone. However, constipation may occur due to the same hormone relaxing smooth muscles and the pressure of the growing baby. Micturition rate may either increase or decrease due to the mass effect of the baby on the bladder and surrounding structures.

Other changes include an increase in uterine size, cervical ectropion, and increased vaginal discharge due to increased mucus production. Cardiovascular changes include an increase in plasma volume, white cell count, platelets, ESR, cholesterol, and fibrinogen, while albumin, urea, and creatinine decrease. Progesterone-related effects include decreased blood pressure, bladder relaxation, biliary stasis, and increased tidal volume.

During pregnancy, a woman’s body undergoes various physiological changes. The cardiovascular system experiences an increase in stroke volume, heart rate, and cardiac output, while systolic blood pressure remains unchanged and diastolic blood pressure decreases in the first and second trimesters before returning to normal levels by term. The enlarged uterus may cause issues with venous return, leading to ankle swelling, supine hypotension, and varicose veins.

The respiratory system sees an increase in pulmonary ventilation and tidal volume, with oxygen requirements only increasing by 20%. This can lead to a sense of dyspnea due to over-breathing and a fall in pCO2. The basal metabolic rate also increases, potentially due to increased thyroxine and adrenocortical hormones.

Maternal blood volume increases by 30%, with red blood cells increasing by 20% and plasma increasing by 50%, leading to a decrease in hemoglobin levels. Coagulant activity increases slightly, while fibrinolytic activity decreases. Platelet count falls, and white blood cell count and erythrocyte sedimentation rate rise.

The urinary system experiences an increase in blood flow and glomerular filtration rate, with elevated sex steroid levels leading to increased salt and water reabsorption and urinary protein losses. Trace glycosuria may also occur.

Calcium requirements increase during pregnancy, with gut absorption increasing substantially due to increased 1,25 dihydroxy vitamin D. Serum levels of calcium and phosphate may fall, but ionized calcium levels remain stable. The liver experiences an increase in alkaline phosphatase and a decrease in albumin levels.

The uterus undergoes significant changes, increasing in weight from 100g to 1100g and transitioning from hyperplasia to hypertrophy. Cervical ectropion and discharge may increase, and Braxton-Hicks contractions may occur in late pregnancy. Retroversion may lead to retention in the first trimester but usually self-corrects.

Haploid cells have one set of chromosomes, diploid cells have two sets, and triploid cells have three sets.

The Process of Spermatogenesis

The process of spermatogenesis is essential for the continuation of our species. It involves diploid mitosis followed by haploid meiosis, resulting in the production of a haploid sperm cell. Unlike females, males have a constant supply of gametes due to the continuous occurrence of spermatogenesis.

Human gametes are haploid cells that contain 23 chromosomes, each of which is individual and one of a pair. Spermatogonial cells undergo constant mitosis, and when they reach the luminal compartment, they become primary spermatocytes. These cells then undergo two stages of meiosis, forming a secondary spermatocyte and then a spermatid. The spermatids migrate to the apex/lumen, where they undergo spermatogenesis, the final maturation and differentiation of the sperm, before being released as sperm cells.

Psammoma bodies, which are collections of calcium, are present in the biopsy findings of a serous cystadenocarcinoma. This type of tumor is characterized by the presence of Walthard cell rests with ‘coffee bean’ nuclei, and would not be lined with mucous-secreting or ciliated cells. The patient’s weight loss is also indicative of a malignant cause.

Types of Ovarian Tumours

There are four main types of ovarian tumours, including surface derived tumours, germ cell tumours, sex cord-stromal tumours, and metastasis. Surface derived tumours are the most common, accounting for around 65% of ovarian tumours, and include the greatest number of malignant tumours. These tumours can be either benign or malignant and include serous cystadenoma, serous cystadenocarcinoma, mucinous cystadenoma, mucinous cystadenocarcinoma, and Brenner tumour. Germ cell tumours are more common in adolescent girls and account for 15-20% of tumours. These tumours are similar to cancer types seen in the testicle and can be either benign or malignant. Examples include teratoma, dysgerminoma, yolk sac tumour, and choriocarcinoma. Sex cord-stromal tumours represent around 3-5% of ovarian tumours and often produce hormones. Examples include granulosa cell tumour, Sertoli-Leydig cell tumour, and fibroma. Metastatic tumours account for around 5% of tumours and include Krukenberg tumour, which is a mucin-secreting signet-ring cell adenocarcinoma resulting from metastases from a gastrointestinal tumour.

The breast is positioned on the superficial fascia, resting on top of the pectoralis major muscle (2/3) and the serratus anterior muscle (1/3). The pectoralis minor muscle is located beneath the pectoralis major muscle, while the deltoid muscle forms the sleek shoulder. Therefore, neither of these muscles come into contact with the breast. The subclavius muscle is situated between the clavicle and the first rib and also does not touch the breast.

The breast is situated on a layer of pectoral fascia and is surrounded by the pectoralis major, serratus anterior, and external oblique muscles. The nerve supply to the breast comes from branches of intercostal nerves from T4-T6, while the arterial supply comes from the internal mammary (thoracic) artery, external mammary artery (laterally), anterior intercostal arteries, and thoraco-acromial artery. The breast’s venous drainage is through a superficial venous plexus to subclavian, axillary, and intercostal veins. Lymphatic drainage occurs through the axillary nodes, internal mammary chain, and other lymphatic sites such as deep cervical and supraclavicular fossa (later in disease).

The preparation for lactation involves the hormones oestrogen, progesterone, and human placental lactogen. Oestrogen promotes duct development in high concentrations, while high levels of progesterone stimulate the formation of lobules. Human placental lactogen prepares the mammary glands for lactation. The two hormones involved in stimulating lactation are prolactin and oxytocin. Prolactin causes milk secretion, while oxytocin causes contraction of the myoepithelial cells surrounding the mammary alveoli to result in milk ejection from the breast. Suckling of the baby stimulates the mechanoreceptors in the nipple, resulting in the release of both prolactin and oxytocin from the pituitary gland (anterior and posterior parts respectively).

Understanding Absence of the Vas Deferens

Absence of the vas deferens is a condition that can occur either unilaterally or bilaterally. In 40% of cases, the cause is due to mutations in the CFTR gene, which is associated with cystic fibrosis. However, in some non-CF cases, the absence of the vas deferens is due to unilateral renal agenesis. Despite this condition, assisted conception may still be possible through sperm harvesting.

It is important to understand the underlying causes of absence of the vas deferens, as it can impact fertility and the ability to conceive. While the condition may be associated with cystic fibrosis, it can also occur independently. However, with advancements in assisted reproductive technologies, individuals with this condition may still have options for starting a family. By seeking medical advice and exploring available options, individuals can make informed decisions about their reproductive health.

The Broad ligament is where the Fallopian tubes are located. If a tubal ectopic pregnancy is detected with a fetal heartbeat, the recommended treatment is a laparoscopic salpingectomy. This surgical procedure involves removing the affected Fallopian tube by accessing it within the Broad ligament. However, if there are other risk factors for infertility, a laparoscopic salpingotomy may be performed instead.

On the other hand, the Cardinal ligament contains the uterine vessels and is not involved in ectopic pregnancy. It may be operated on in cases of uterine fibroids through a laparoscopic myomectomy.

The Ovarian ligament attaches the ovaries to the uterus but does not contain any structures. Meanwhile, the Round ligament attaches the uterine fundus to the labia majora but also does not contain any structures.

Pelvic Ligaments and their Connections

Pelvic ligaments are structures that connect various organs within the female reproductive system to the pelvic wall. These ligaments play a crucial role in maintaining the position and stability of these organs. There are several types of pelvic ligaments, each with its own unique function and connection.

The broad ligament connects the uterus, fallopian tubes, and ovaries to the pelvic wall, specifically the ovaries. The round ligament connects the uterine fundus to the labia majora, but does not connect to any other structures. The cardinal ligament connects the cervix to the lateral pelvic wall and is responsible for supporting the uterine vessels. The suspensory ligament of the ovaries connects the ovaries to the lateral pelvic wall and supports the ovarian vessels. The ovarian ligament connects the ovaries to the uterus, but does not connect to any other structures. Finally, the uterosacral ligament connects the cervix and posterior vaginal dome to the sacrum, but does not connect to any other structures.

Overall, pelvic ligaments are essential for maintaining the proper position and function of the female reproductive organs. Understanding the connections between these ligaments and the structures they support is crucial for diagnosing and treating any issues that may arise.

Anatomy of the Ovarian Follicle

The ovarian follicle is a complex structure that plays a crucial role in female reproductive function. It consists of several components, including granulosa cells, the zona pellucida, the theca, the antrum, and the cumulus oophorus.

Granulosa cells are responsible for producing oestradiol, which is essential for follicular development. Once the follicle becomes the corpus luteum, granulosa lutein cells produce progesterone, which is necessary for embryo implantation. The zona pellucida is a membrane that surrounds the oocyte and contains the protein ZP3, which is responsible for sperm binding.

The theca produces androstenedione, which is converted into oestradiol by granulosa cells. The antrum is a fluid-filled portion of the follicle that marks the transition of a primary oocyte into a secondary oocyte. Finally, the cumulus oophorus is a cluster of cells surrounding the oocyte that must be penetrated by spermatozoa for fertilisation to occur.

Understanding the anatomy of the ovarian follicle is essential for understanding female reproductive function and fertility. Each component plays a unique role in the development and maturation of the oocyte, as well as in the processes of fertilisation and implantation.

Anastrozole and letrozole are medications that inhibit the production of oestrogen in peripheral tissues through the enzyme aromatase. These drugs are commonly used to treat breast cancer in postmenopausal women.

Trastuzumab is a monoclonal antibody that targets HER2 receptors on cancer cells, inhibiting their growth and proliferation. It is effective in treating HER2-positive breast cancer.

Fulvestrant is a selective oestrogen receptor degrader that breaks down oestrogen receptors without activating them, unlike tamoxifen. This leads to downregulation of the receptor.

Goserelin is an LHRH agonist that suppresses oestrogen production by the ovaries. It is often used as adjuvant therapy in premenopausal women.

Tamoxifen is an antagonist (and partial agonist) of the oestrogen receptor. It is particularly useful in treating oestrogen-receptor positive breast cancer, especially in patients who have not yet gone through menopause.

Anti-oestrogen drugs are used in the management of oestrogen receptor-positive breast cancer. Selective oEstrogen Receptor Modulators (SERM) such as Tamoxifen act as an oestrogen receptor antagonist and partial agonist. However, Tamoxifen may cause adverse effects such as menstrual disturbance, hot flushes, venous thromboembolism, and endometrial cancer. On the other hand, aromatase inhibitors like Anastrozole and Letrozole reduce peripheral oestrogen synthesis, which is important in postmenopausal women. Anastrozole is used for ER +ve breast cancer in this group. However, aromatase inhibitors may cause adverse effects such as osteoporosis, hot flushes, arthralgia, myalgia, and insomnia. NICE recommends a DEXA scan when initiating a patient on aromatase inhibitors for breast cancer.

To obtain fluid from the rectouterine pouch, a needle is inserted through the posterior fornix of the vagina.

The vagina has four fornices, including the anterior, posterior, and two lateral fornices. The anterior fornix of the vagina is closely associated with the vesicouterine pouch.

Culdocentesis is a procedure that involves using a needle to extract fluid from the rectouterine pouch (also known as the pouch of Douglas) through the posterior fornix of the vagina.

Culdocentesis is now mostly replaced by ultrasound examination and minimally invasive surgery, such as in cases of ectopic pregnancy.

Anatomy of the Uterus

The uterus is a female reproductive organ that is located within the pelvis and is covered by the peritoneum. It is supplied with blood by the uterine artery, which runs alongside the uterus and anastomoses with the ovarian artery. The uterus is supported by various ligaments, including the central perineal tendon, lateral cervical, round, and uterosacral ligaments. The ureter is located close to the uterus, and injuries to the ureter can occur when there is pathology in the area.

The uterus is typically anteverted and anteflexed in most women. Its topography can be visualized through imaging techniques such as ultrasound or MRI. Understanding the anatomy of the uterus is important for diagnosing and treating various gynecological conditions.

How does the Combined Oral Contraceptive Pill work?

The Combined Oral Contraceptive Pill (COC) is a widely used method of contraception in the UK. It works by preventing ovulation, which means that an egg is not released from the ovaries. In addition to this, the COC also thickens the cervical mucus, making it more difficult for sperm to enter the uterus, and thins the endometrial lining, reducing the chance of implantation.

By combining these three actions, the COC is highly effective at preventing pregnancy. It is important to note that the COC does not protect against sexually transmitted infections (STIs), so additional protection such as condoms should be used if there is a risk of STIs.

The patient is experiencing secondary amenorrhoea, which is indicative of hypothalamic amenorrhoea due to low-level gonadotrophins. This could be caused by the patient’s intensive training for marathons, as well as other risk factors such as stress and anorexia nervosa. Hyperthyroidism is unlikely as the patient does not exhibit any symptoms or abnormal thyroid function test results. Polycystic ovarian syndrome (PCOS) can be ruled out as the patient does not have hirsutism, a high BMI, or elevated LH and FSH levels. Pregnancy is also not a possibility as the patient’s test was negative and she does not exhibit any signs of pregnancy.

Understanding Amenorrhoea: Causes, Investigations, and Management

Amenorrhoea is a condition characterized by the absence of menstrual periods. It can be classified into two types: primary and secondary. Primary amenorrhoea occurs when menstruation fails to start by the age of 15 in girls with normal secondary sexual characteristics or by the age of 13 in girls with no secondary sexual characteristics. On the other hand, secondary amenorrhoea is the cessation of menstruation for 3-6 months in women with previously normal and regular menses or 6-12 months in women with previous oligomenorrhoea.

The causes of amenorrhoea vary depending on the type. Primary amenorrhoea may be caused by gonadal dysgenesis, testicular feminization, congenital malformations of the genital tract, functional hypothalamic amenorrhoea, congenital adrenal hyperplasia, imperforate hymen, hypothalamic amenorrhoea, polycystic ovarian syndrome, hyperprolactinemia, premature ovarian failure, and thyrotoxicosis. Meanwhile, secondary amenorrhoea may be caused by stress, excessive exercise, PCOS, Sheehan’s syndrome, Asherman’s syndrome, and other underlying medical conditions.

To diagnose amenorrhoea, initial investigations may include pregnancy tests, full blood count, urea & electrolytes, coeliac screen, thyroid function tests, gonadotrophins, prolactin, and androgen levels. Management of amenorrhoea involves treating the underlying cause. For primary amenorrhoea, it is important to investigate and treat any underlying cause. For secondary amenorrhoea, it is important to exclude pregnancy, lactation, and menopause and treat the underlying cause accordingly. Women with primary ovarian insufficiency due to gonadal dysgenesis may benefit from hormone replacement therapy to prevent osteoporosis and other complications.

In conclusion, amenorrhoea is a condition that requires proper diagnosis and management. Understanding the causes and appropriate investigations can help in providing the necessary treatment and care for women experiencing this condition.

The most frequent cause of infection is Staphylococcus aureus, which typically enters through damage to the nipple areolar complex caused by the infant’s mouth.

Breast Abscess: Causes and Management

Breast abscess is a condition that commonly affects lactating women, with Staphylococcus aureus being the most common cause. The condition is characterized by the presence of a tender, fluctuant mass in the breast.

To manage breast abscess, healthcare providers may opt for either incision and drainage or needle aspiration, with the latter typically done using ultrasound. Antibiotics are also prescribed to help treat the infection.

Breast abscess can be a painful and uncomfortable condition for lactating women. However, with prompt and appropriate management, the condition can be effectively treated, allowing women to continue breastfeeding their babies without any complications.

The correct diagnosis for this patient is endometriosis, as she exhibits the typical symptoms of vague pelvic pain, deep dyspareunia, and pain during defecation. These symptoms are caused by the presence of extra-pelvic endometrial tissue that bleeds and irritates the bowel or recto-vaginal pouch.

Adenomyosis, on the other hand, typically presents with dysmenorrhoea, dyspareunia, and menorrhagia, which are not present in this patient.

Pelvic inflammatory disease may cause pelvic pain and deep dyspareunia, but it is usually chronic and not cyclical like the pain experienced by this patient. Pain during defecation is also not a common symptom.

Fibroids may cause pelvic pain, but they do not typically cause dyspareunia or pain during defecation. Menorrhagia is a common symptom of fibroids.

Endometriosis is a condition where endometrial tissue grows outside of the uterus, affecting around 10% of women of reproductive age. Symptoms include chronic pelvic pain, painful periods, pain during sex, and subfertility. Diagnosis is made through laparoscopy, and treatment depends on the severity of symptoms. First-line treatments include NSAIDs and hormonal treatments such as the combined oral contraceptive pill or progestogens. If these do not improve symptoms or fertility is a priority, referral to secondary care may be necessary. Treatment options in secondary care include GnRH analogues and surgery, with laparoscopic excision or ablation of endometriosis plus adhesiolysis recommended for women trying to conceive. Ovarian cystectomy may also be necessary for endometriomas.

Understanding Ovarian Cancer: Risk Factors, Symptoms, and Management

Ovarian cancer is a type of cancer that affects women, with the peak age of incidence being 60 years. It is the fifth most common malignancy in females and carries a poor prognosis due to late diagnosis. Around 90% of ovarian cancers are epithelial in origin, with 70-80% of cases being due to serous carcinomas. Interestingly, recent studies suggest that the distal end of the fallopian tube is often the site of origin of many ‘ovarian’ cancers.

There are several risk factors associated with ovarian cancer, including a family history of mutations of the BRCA1 or the BRCA2 gene, early menarche, late menopause, and nulliparity. Clinical features of ovarian cancer are notoriously vague and can include abdominal distension and bloating, abdominal and pelvic pain, urinary symptoms, early satiety, and diarrhea.

To diagnose ovarian cancer, a CA125 test is usually done initially. If the CA125 level is raised, an urgent ultrasound scan of the abdomen and pelvis should be ordered. However, a CA125 should not be used for screening for ovarian cancer in asymptomatic women. Diagnosis is difficult and usually involves diagnostic laparotomy.

Management of ovarian cancer usually involves a combination of surgery and platinum-based chemotherapy. The prognosis for ovarian cancer is poor, with 80% of women having advanced disease at presentation and the all stage 5-year survival being 46%. It is traditionally taught that infertility treatment increases the risk of ovarian cancer, as it increases the number of ovulations. However, recent evidence suggests that there is not a significant link. The combined oral contraceptive pill reduces the risk (fewer ovulations) as does having many pregnancies.

Within the broad ligament of the uterus, one can locate the ovaries and the fallopian tubes.

Pelvic Ligaments and their Connections

Pelvic ligaments are structures that connect various organs within the female reproductive system to the pelvic wall. These ligaments play a crucial role in maintaining the position and stability of these organs. There are several types of pelvic ligaments, each with its own unique function and connection.

The broad ligament connects the uterus, fallopian tubes, and ovaries to the pelvic wall, specifically the ovaries. The round ligament connects the uterine fundus to the labia majora, but does not connect to any other structures. The cardinal ligament connects the cervix to the lateral pelvic wall and is responsible for supporting the uterine vessels. The suspensory ligament of the ovaries connects the ovaries to the lateral pelvic wall and supports the ovarian vessels. The ovarian ligament connects the ovaries to the uterus, but does not connect to any other structures. Finally, the uterosacral ligament connects the cervix and posterior vaginal dome to the sacrum, but does not connect to any other structures.

Overall, pelvic ligaments are essential for maintaining the proper position and function of the female reproductive organs. Understanding the connections between these ligaments and the structures they support is crucial for diagnosing and treating any issues that may arise.

The let-down or milk ejection reflex is explained by the midwife as being stimulated by oxytocin. This hormone triggers the contraction of the myoepithelial cells in the alveoli of the mammary glands, leading to milk contraction.

Understanding Oxytocin: The Hormone Responsible for Let-Down Reflex and Uterine Contraction

Oxytocin is a hormone composed of nine amino acids that is produced by the paraventricular nuclei of the hypothalamus and released by the posterior pituitary gland. Its primary function is to stimulate the let-down reflex of lactation by causing the contraction of the myoepithelial cells of the alveoli of the mammary glands. It also promotes uterine contraction, which is essential during childbirth.

Oxytocin secretion increases during infant suckling and may also increase during orgasm. A synthetic version of oxytocin, called Syntocinon, is commonly administered during the third stage of labor and is used to manage postpartum hemorrhage. However, oxytocin administration can also have adverse effects, such as uterine hyperstimulation, water intoxication, and hyponatremia.

In summary, oxytocin plays a crucial role in lactation and childbirth. Its secretion is regulated by infant suckling and can also increase during sexual activity. While oxytocin administration can be beneficial in certain situations, it is important to be aware of its potential adverse effects.

A uterus that is larger than expected for the stage of pregnancy is a strong indication of a molar pregnancy. The patient is experiencing hyperemesis and overall discomfort, which can be attributed to the elevated levels of B-hcG in her bloodstream, as confirmed by a blood test.

Gestational trophoblastic disorders refer to a range of conditions that originate from the placental trophoblast. These disorders include complete hydatidiform mole, partial hydatidiform mole, and choriocarcinoma. Complete hydatidiform mole is a benign tumor of trophoblastic material that occurs when an empty egg is fertilized by a single sperm that duplicates its own DNA, resulting in all 46 chromosomes being of paternal origin. Symptoms of this disorder include bleeding in the first or early second trimester, exaggerated pregnancy symptoms, a large uterus for dates, and high levels of human chorionic gonadotropin (hCG) in the blood. Hypertension and hyperthyroidism may also be present. Urgent referral to a specialist center is necessary, and evacuation of the uterus is performed. Effective contraception is recommended to avoid pregnancy in the next 12 months. About 2-3% of cases may progress to choriocarcinoma. In partial mole, a normal haploid egg may be fertilized by two sperms or one sperm with duplication of paternal chromosomes, resulting in DNA that is both maternal and paternal in origin. Fetal parts may be visible, and the condition is usually triploid.

Call-Exner bodies are a characteristic feature of ovarian granulosa cell tumors, consisting of disorganized granulosa cells surrounding small fluid-filled spaces. Patients with ovarian malignancies often present with nonspecific symptoms such as abdominal discomfort and weight loss, leading to delayed diagnosis. The most common type of malignant stromal tumor of the ovary is granulosa cell tumor, which may be identified by the presence of Call-Exner bodies on histopathology. Other types of ovarian neoplasms include mucinous cystadenocarcinoma, serous cystadenoma, and serous cystadenocarcinoma, each with their own distinct features on histopathology.

Types of Ovarian Tumours

There are four main types of ovarian tumours, including surface derived tumours, germ cell tumours, sex cord-stromal tumours, and metastasis. Surface derived tumours are the most common, accounting for around 65% of ovarian tumours, and include the greatest number of malignant tumours. These tumours can be either benign or malignant and include serous cystadenoma, serous cystadenocarcinoma, mucinous cystadenoma, mucinous cystadenocarcinoma, and Brenner tumour. Germ cell tumours are more common in adolescent girls and account for 15-20% of tumours. These tumours are similar to cancer types seen in the testicle and can be either benign or malignant. Examples include teratoma, dysgerminoma, yolk sac tumour, and choriocarcinoma. Sex cord-stromal tumours represent around 3-5% of ovarian tumours and often produce hormones. Examples include granulosa cell tumour, Sertoli-Leydig cell tumour, and fibroma. Metastatic tumours account for around 5% of tumours and include Krukenberg tumour, which is a mucin-secreting signet-ring cell adenocarcinoma resulting from metastases from a gastrointestinal tumour.

Cystic Fibrosis Inheritance

Cystic fibrosis is a genetic disorder that is inherited in an autosomal recessive pattern. This means that both copies of the gene in each cell have mutations. Individuals with only one copy of the mutated gene are carriers and typically do not show signs or symptoms of the condition.

In the case of a female carrier for the CF gene, there is a 1 in 2 chance of producing a gamete carrying the CF gene. If her new partner is also a carrier, he has a 1 in 25 chance of having the CF gene and a 1 in 50 chance of producing a gamete with the CF gene. Therefore, the chance of producing a child with cystic fibrosis is 1 in 100.

It is important to understand the inheritance pattern of cystic fibrosis to make informed decisions about family planning and genetic testing. This knowledge can help individuals and families better understand the risks and potential outcomes of having children with this condition.

When it comes to fibroids and difficulty conceiving, submucosal fibroids are the most likely culprit. These fibroids are located in the uterine cavity and can interfere with the implantation of an embryo. Intramural and subserosal fibroids are less likely to cause fertility issues, but they can cause symptoms such as increased urinary frequency and constipation due to their size and location. It’s important to note that fibroids are typically found within the uterus and not outside of it.

Understanding Uterine Fibroids

Uterine fibroids are non-cancerous growths that develop in the uterus. They are more common in black women and are believed to occur in around 20% of white women in their later reproductive years. Fibroids are usually asymptomatic, but they can cause menorrhagia, which can lead to iron-deficiency anaemia. Other symptoms include lower abdominal pain, bloating, and urinary symptoms. Fibroids may also cause subfertility, but this is rare.

Diagnosis is usually done through transvaginal ultrasound. Asymptomatic fibroids do not require treatment, but periodic monitoring is necessary. For menorrhagia, treatment options include the levonorgestrel intrauterine system, NSAIDs, tranexamic acid, oral progestogen, and injectable progestogen. Medical treatment to shrink or remove fibroids includes GnRH agonists and ulipristal acetate, while surgical options include myomectomy, hysteroscopic endometrial ablation, hysterectomy, and uterine artery embolization.

Fibroids generally regress after menopause, and complications such as subfertility and iron-deficiency anaemia have been mentioned previously. Another complication is red degeneration, which is haemorrhage into the tumour and commonly occurs during pregnancy. Understanding uterine fibroids is important for women’s health, and seeking medical attention is necessary if symptoms arise.

The patient’s history of previous cesarean deliveries and the presence of fibroids suggest that she may be at a higher risk for postpartum hemorrhage due to uterine atony. This is compounded by her multiparity, which further increases her risk.

Postpartum Haemorrhage: Causes, Risk Factors, and Management

Postpartum haemorrhage (PPH) is a condition characterized by excessive blood loss of more than 500 ml after a vaginal delivery. It can be primary or secondary. Primary PPH occurs within 24 hours after delivery and is caused by the 4 Ts: tone, trauma, tissue, and thrombin. The most common cause is uterine atony. Risk factors for primary PPH include previous PPH, prolonged labour, pre-eclampsia, increased maternal age, emergency Caesarean section, and placenta praevia. Management of PPH is a life-threatening emergency that requires immediate involvement of senior staff. The ABC approach is used, and bloods are taken, including group and save. Medical management includes IV oxytocin, ergometrine, carboprost, and misoprostol. Surgical options are considered if medical management fails to control the bleeding. Secondary PPH occurs between 24 hours to 6 weeks after delivery and is typically due to retained placental tissue or endometritis.

Understanding Postpartum Haemorrhage

Postpartum haemorrhage is a serious condition that can occur after vaginal delivery. It is important to understand the causes, risk factors, and management of this condition to ensure prompt and effective treatment. Primary PPH is caused by the 4 Ts, with uterine atony being the most common cause. Risk factors for primary PPH include previous PPH, prolonged labour, and emergency Caesarean section. Management of PPH is a life-threatening emergency that requires immediate involvement of senior staff. Medical management includes IV oxytocin, ergometrine, carboprost, and misoprostol. Surgical options are considered if medical management fails to control the bleeding. Secondary PPH occurs between 24 hours to 6 weeks after delivery and is typically due to retained placental tissue or endometritis. It is important to be aware of the signs and symptoms of PPH and seek medical attention immediately if they occur.

The presence of ↑ HCG, ↓ PAPP-A, and a thickened nuchal translucency is indicative of Down’s syndrome. The combined screening test, which includes an ultrasound scan and blood test, is used to assess the risk of the fetus having Down’s syndrome, Edwards’ syndrome, and Patau’s syndrome. However, a diagnostic test such as amniocentesis or chorionic villus sampling is required to confirm the diagnosis. Advanced maternal age is also a significant risk factor for Down’s syndrome. The answer choices ‘↑ HCG, ↑ PAPP-A, increased amount of nuchal fluid’, ‘↑ HCG, ↓ PAPP-A, normal amount of nuchal fluid’, and ‘↓ HCG, ↓ PAPP-A, decreased amount of nuchal fluid’ are incorrect as they do not match the typical indicators of Down’s syndrome.

NICE updated guidelines on antenatal care in 2021, recommending the combined test for screening for Down’s syndrome between 11-13+6 weeks. The quadruple test should be offered between 15-20 weeks for women who book later in pregnancy. Results of both tests return either a ‘lower chance’ or ‘higher chance’ result. If a woman receives a ‘higher chance’ result, she will be offered a second screening test (NIPT) or a diagnostic test. NIPT analyzes cell-free fetal DNA from placental cells in the mother’s blood and has high sensitivity and specificity for detecting chromosomal abnormalities, with private companies offering screening from 10 weeks gestation.

PPH is the loss of >500ml blood within 24 hours of delivery. Uterine atony is the most common cause, followed by retained placenta.

Postpartum Haemorrhage: Causes, Risk Factors, and Management

Postpartum haemorrhage (PPH) is a condition characterized by excessive blood loss of more than 500 ml after a vaginal delivery. It can be primary or secondary. Primary PPH occurs within 24 hours after delivery and is caused by the 4 Ts: tone, trauma, tissue, and thrombin. The most common cause is uterine atony. Risk factors for primary PPH include previous PPH, prolonged labour, pre-eclampsia, increased maternal age, emergency Caesarean section, and placenta praevia. Management of PPH is a life-threatening emergency that requires immediate involvement of senior staff. The ABC approach is used, and bloods are taken, including group and save. Medical management includes IV oxytocin, ergometrine, carboprost, and misoprostol. Surgical options are considered if medical management fails to control the bleeding. Secondary PPH occurs between 24 hours to 6 weeks after delivery and is typically due to retained placental tissue or endometritis.

Understanding Postpartum Haemorrhage

Postpartum haemorrhage is a serious condition that can occur after vaginal delivery. It is important to understand the causes, risk factors, and management of this condition to ensure prompt and effective treatment. Primary PPH is caused by the 4 Ts, with uterine atony being the most common cause. Risk factors for primary PPH include previous PPH, prolonged labour, and emergency Caesarean section. Management of PPH is a life-threatening emergency that requires immediate involvement of senior staff. Medical management includes IV oxytocin, ergometrine, carboprost, and misoprostol. Surgical options are considered if medical management fails to control the bleeding. Secondary PPH occurs between 24 hours to 6 weeks after delivery and is typically due to retained placental tissue or endometritis. It is important to be aware of the signs and symptoms of PPH and seek medical attention immediately if they occur.

First-line treatment for urinary incontinence is bladder retraining for urge incontinence and pelvic floor muscle training for stress incontinence. Surgery is a later option. Toileting aids and decreasing fluid intake should not be advised. Patients should drink 6-8 glasses of water per day.

Urinary incontinence is a common condition that affects approximately 4-5% of the population, with elderly females being more susceptible. There are several risk factors that can contribute to the development of urinary incontinence, including advancing age, previous pregnancy and childbirth, high body mass index, hysterectomy, and family history. The condition can be classified into different types, such as overactive bladder, stress incontinence, mixed incontinence, overflow incontinence, and functional incontinence.

Initial investigation of urinary incontinence involves completing bladder diaries for at least three days, performing a vaginal examination to exclude pelvic organ prolapse, and conducting urine dipstick and culture tests. Urodynamic studies may also be necessary. Management of urinary incontinence depends on the predominant type of incontinence. For urge incontinence, bladder retraining and bladder stabilizing drugs such as antimuscarinics are recommended. For stress incontinence, pelvic floor muscle training and surgical procedures may be necessary. Duloxetine, a combined noradrenaline and serotonin reuptake inhibitor, may also be offered to women who decline surgical procedures.

In summary, urinary incontinence is a common condition that can be caused by various risk factors. It can be classified into different types, and management depends on the predominant type of incontinence. Initial investigation involves completing bladder diaries, performing a vaginal examination, and conducting urine tests. Treatment options include bladder retraining, bladder stabilizing drugs, pelvic floor muscle training, surgical procedures, and duloxetine.

Placental abruption is suggested by several factors in this scenario, including the woman’s age (which increases the risk), high parity, the onset of clinical shock, and most notably, a tender and hard uterus upon examination. Given the gestational age, an ectopic pregnancy or miscarriage is unlikely, and while placenta previa is a common cause of antepartum hemorrhage, it typically presents with painless vaginal bleeding.

Placental Abruption: Causes, Symptoms, and Risk Factors

Placental abruption is a condition that occurs when the placenta separates from the uterine wall, leading to maternal bleeding into the space between the placenta and the uterus. Although the exact cause of placental abruption is unknown, certain factors have been associated with the condition, including proteinuric hypertension, cocaine use, multiparity, maternal trauma, and increasing maternal age. Placental abruption is relatively rare, occurring in approximately 1 out of 200 pregnancies.

The clinical features of placental abruption include shock that is disproportionate to the visible blood loss, constant pain, a tender and tense uterus, a normal lie and presentation, and absent or distressed fetal heart sounds. Coagulation problems may also occur, and it is important to be aware of the potential for pre-eclampsia, disseminated intravascular coagulation (DIC), and anuria.

In summary, placental abruption is a serious condition that can have significant consequences for both the mother and the fetus. Understanding the risk factors and symptoms of placental abruption is important for early detection and prompt treatment.

A classic characteristic of invasive lobular carcinoma is the possibility of metastasis to the opposite breast.

Understanding Lobular Carcinoma of the Breast

Lobular carcinoma of the breast is a less common type of breast cancer that presents differently from ductal carcinoma. The mass is usually more diffuse and less obvious on imaging tests like ultrasound and mammography, which can result in inadequate treatment if the disease is understaged. For women with invasive lobular carcinoma, an MRI scan of the breast is usually recommended before breast conserving surgery is performed to ensure the safest approach.

Lobular carcinomas are also more likely to be multifocal and metastasize to the opposite breast. In some cases, lobular carcinoma in situ may be diagnosed incidentally on core biopsies. Unlike ductal carcinoma in situ, lobular carcinoma in situ is less strongly associated with foci of invasion and is usually managed through close monitoring. Understanding the differences between lobular and ductal carcinoma can help healthcare professionals provide the best possible care for patients with breast cancer.

The woman has HELLP syndrome, a severe form of pre-eclampsia. Management includes magnesium sulfate, dexamethasone, blood pressure control, and blood product replacement. Delivery of the fetus is the only cure.

Pre-eclampsia is a condition that occurs during pregnancy and is characterized by high blood pressure, proteinuria, and edema. It can lead to complications such as eclampsia, neurological issues, fetal growth problems, liver involvement, and cardiac failure. Severe pre-eclampsia is marked by hypertension, proteinuria, headache, visual disturbances, and other symptoms. Risk factors for pre-eclampsia include hypertension in a previous pregnancy, chronic kidney disease, autoimmune disease, diabetes, chronic hypertension, first pregnancy, age over 40, high BMI, family history of pre-eclampsia, and multiple pregnancy. To reduce the risk of hypertensive disorders in pregnancy, women with high or moderate risk factors should take aspirin daily. Management involves emergency assessment, admission for severe cases, and medication such as labetalol, nifedipine, or hydralazine. Delivery of the baby is the most important step in management, with timing depending on the individual case.

When the baby has Rh-positive blood and the mother has Rh-negative blood, their blood supplies can mix during pregnancy. This can lead to the mother producing antibodies that may harm the baby by passing through the placenta and causing conditions like hydrops fetalis. Additionally, subsequent pregnancies may also be impacted.

Rhesus negative mothers can develop anti-D IgG antibodies if they deliver a Rh +ve child, which can cause haemolysis in future pregnancies. Prevention involves testing for D antibodies and giving anti-D prophylaxis at 28 and 34 weeks. Anti-D should also be given in various situations, such as delivery of a Rh +ve infant or amniocentesis. Tests include cord blood FBC, blood group, direct Coombs test, and Kleihauer test. Affected fetuses may experience oedema, jaundice, anaemia, hepatosplenomegaly, heart failure, and kernicterus, and may require transfusions and UV phototherapy.

Polycystic ovary syndrome leads to anovulation with normal levels of FSH and estrogen, known as normogonadotropic normoestrogenic anovulation. LH levels may be elevated or normal in this condition.

Hypogonadotropic hypogonadal anovulation is caused by hypopituitarism or hyperprolactinemia, resulting in low levels of gonadotropins and estrogen. However, hyperprolactinemia can be ruled out based on gonadotropin and estrogen levels alone.

Hypothalamic amenorrhea is a functional cause of hypogonadotropic hypogonadal anovulation, often due to factors such as low BMI, stress, or excessive exercise.

Understanding Ovulation Induction and Its Categories

Ovulation induction is a common treatment for couples who have difficulty conceiving naturally due to ovulation disorders. The process of ovulation requires a balance of hormones and feedback loops between the hypothalamus, pituitary gland, and ovaries. Anovulation can occur due to alterations in this balance, which can be classified into three categories: hypogonadotropic hypogonadal anovulation, normogonadotropic normoestrogenic anovulation, and hypergonadotropic hypoestrogenic anovulation. The goal of ovulation induction is to induce mono-follicular development and subsequent ovulation, leading to a singleton pregnancy.

There are various forms of ovulation induction, starting with the least invasive and simplest management option first. Exercise and weight loss are typically the first-line treatment for patients with polycystic ovarian syndrome, as ovulation can spontaneously return with even a modest 5% weight loss. Letrozole is now considered the first-line medical therapy for patients with PCOS due to its reduced risk of adverse effects on endometrial and cervical mucous compared to clomiphene citrate. Clomiphene citrate is a selective estrogen receptor modulator that acts primarily at the hypothalamus, blocking the negative feedback effect of estrogens. Gonadotropin therapy tends to be the treatment used mostly for women with hypogonadotropic hypogonadism.

One potential side effect of ovulation induction is ovarian hyperstimulation syndrome (OHSS), which can be life-threatening if not identified and managed promptly. OHSS occurs when ovarian enlargement with multiple cystic spaces form, and an increase in the permeability of capillaries leads to a fluid shift from the intravascular to the extra-vascular space. The severity of OHSS varies, with the risk of severe OHSS occurring in less than 1% of all women undergoing ovarian induction. Management includes fluid and electrolyte replacement, anticoagulation therapy, abdominal ascitic paracentesis, and pregnancy termination to prevent further hormonal imbalances.

Smoking is a protective factor against only one type of cancer, which is endometrial cancer (3), as found by a meta-analysis. However, smoking is a risk factor for all the other types of cancer mentioned.

For bladder cancer (1), it is suggested that the aromatic amines found in cigarettes are a known carcinogen of the bladder, thus contributing to the increased risk of bladder cancer with smoking.

Although smoking is a well-established co-factor for the development of cervical cancer (2), the mechanism by which smoking increases the risk is not known, although there are two theories.

Smoking has been found to cause numerous DNA changes in laryngeal cancer (4), including TP53 gene mutations.

Smoking is also theorized to cause renal cell cancer (5) as cigarette smoke induces oxidative stress and injury in the kidney, and free radicals in cigarettes can cause DNA damage that may lead to the development of cancer.

Endometrial cancer is a type of cancer that is commonly found in women who have gone through menopause, but it can also occur in around 25% of cases before menopause. The prognosis for this type of cancer is usually good due to early detection. There are several risk factors associated with endometrial cancer, including obesity, nulliparity, early menarche, late menopause, unopposed estrogen, diabetes mellitus, tamoxifen, polycystic ovarian syndrome, and hereditary non-polyposis colorectal carcinoma. Symptoms of endometrial cancer include postmenopausal bleeding, which is usually slight and intermittent at first before becoming heavier, and changes in intermenstrual bleeding for premenopausal women. Pain is not common and typically signifies extensive disease, while vaginal discharge is unusual.

When investigating endometrial cancer, women who are 55 years or older and present with postmenopausal bleeding should be referred using the suspected cancer pathway. The first-line investigation is trans-vaginal ultrasound, which has a high negative predictive value for a normal endometrial thickness of less than 4 mm. Hysteroscopy with endometrial biopsy is also commonly used for diagnosis. Treatment for localized disease typically involves total abdominal hysterectomy with bilateral salpingo-oophorectomy, while patients with high-risk disease may require postoperative radiotherapy. Progestogen therapy may be used in frail elderly women who are not considered suitable for surgery. It is important to note that the combined oral contraceptive pill and smoking are protective against endometrial cancer.

The cardinal ligament is responsible for connecting the cervix to the lateral pelvic wall. When this ligament, along with the uterosacral ligament, becomes weak, it can lead to uterine prolapse. It is important not to confuse the ovarian ligament, which connects the ovaries and uterus but does not contain blood vessels, with the suspensory ligament that contains the ovary’s neurovascular supply and connects the ovary, uterus, and pelvic wall. The pubocervical ligament, which connects the cervix to the posterior aspect of the pubic bone, can also weaken and cause vaginal prolapse. Finally, the round ligament connects the uterine fundus and the labia majora.

Pelvic Ligaments and their Connections

Pelvic ligaments are structures that connect various organs within the female reproductive system to the pelvic wall. These ligaments play a crucial role in maintaining the position and stability of these organs. There are several types of pelvic ligaments, each with its own unique function and connection.

The broad ligament connects the uterus, fallopian tubes, and ovaries to the pelvic wall, specifically the ovaries. The round ligament connects the uterine fundus to the labia majora, but does not connect to any other structures. The cardinal ligament connects the cervix to the lateral pelvic wall and is responsible for supporting the uterine vessels. The suspensory ligament of the ovaries connects the ovaries to the lateral pelvic wall and supports the ovarian vessels. The ovarian ligament connects the ovaries to the uterus, but does not connect to any other structures. Finally, the uterosacral ligament connects the cervix and posterior vaginal dome to the sacrum, but does not connect to any other structures.

Overall, pelvic ligaments are essential for maintaining the proper position and function of the female reproductive organs. Understanding the connections between these ligaments and the structures they support is crucial for diagnosing and treating any issues that may arise.

A pregnant woman who has 3 risk factors should receive LMWH from 28 weeks until 6 weeks after giving birth. If she has more than 3 risk factors, she should start LMWH immediately and continue until 6 weeks postnatal.

The risk factors for thromboprophylaxis include age over 35, a body mass index over 30, parity over 3, smoking, gross varicose veins, current pre-eclampsia, immobility, family history of unprovoked VTE, low risk thrombophilia, multiple pregnancy, and IVF pregnancy.

In this particular case, the woman has 4 risk factors, including being 36 years old, a smoker, having a parity over 3, and a body mass index of 33. Therefore, she needs to begin taking low molecular weight heparin immediately and continue until 6 weeks after giving birth.

While all pregnant women should be advised to stay mobile and hydrated, this woman requires medical treatment due to her increased risk factors.

Pregnancy increases the risk of developing venous thromboembolism (VTE), which is why it is important to assess a woman’s individual risk during pregnancy and take appropriate prophylactic measures. A risk assessment should be conducted at the time of booking and on any subsequent hospital admission. Women with a previous VTE history are automatically considered high risk and require low molecular weight heparin throughout the antenatal period, along with input from experts. Women at intermediate risk due to hospitalization, surgery, comorbidities, or thrombophilia should also be considered for antenatal prophylactic low molecular weight heparin.

The risk assessment at booking should include factors that increase the likelihood of developing VTE, such as age over 35, body mass index over 30, parity over 3, smoking, gross varicose veins, current pre-eclampsia, immobility, family history of unprovoked VTE, low-risk thrombophilia, multiple pregnancy, and IVF pregnancy. If a woman has four or more risk factors, immediate treatment with low molecular weight heparin should be initiated and continued until six weeks postnatal. If a woman has three risk factors, low molecular weight heparin should be initiated from 28 weeks and continued until six weeks postnatal.

If a diagnosis of DVT is made shortly before delivery, anticoagulation treatment should be continued for at least three months, as in other patients with provoked DVTs. Low molecular weight heparin is the preferred treatment for VTE prophylaxis in pregnancy, while Direct Oral Anticoagulants (DOACs) and warfarin should be avoided. By taking these measures, the risk of developing VTE during pregnancy can be reduced.

The production of testosterone in response to LH is carried out by Leydig cells, not Sertoli cells in the testes.

Leydig cells are responsible for the secretion of testosterone when LH is released from the anterior pituitary gland. On the other hand, Sertoli cells are referred to as nurse cells because they provide nourishment to developing sperm during spermatogenesis. These cells have an elongated shape, secrete androgen-binding protein and tubular fluid, support the development of sperm during spermatogenesis, and form the blood-testes barrier.

Endocrine Changes During Pregnancy

During pregnancy, there are several physiological changes that occur in the body, including endocrine changes. Progesterone, which is produced by the fallopian tubes during the first two weeks of pregnancy, stimulates the secretion of nutrients required by the zygote/blastocyst. At six weeks, the placenta takes over the production of progesterone, which inhibits uterine contractions by decreasing sensitivity to oxytocin and inhibiting the production of prostaglandins. Progesterone also stimulates the development of lobules and alveoli.

Oestrogen, specifically oestriol, is another major hormone produced during pregnancy. It stimulates the growth of the myometrium and the ductal system of the breasts. Prolactin, which increases during pregnancy, initiates and maintains milk secretion of the mammary gland. It is essential for the expression of the mammotropic effects of oestrogen and progesterone. However, oestrogen and progesterone directly antagonize the stimulating effects of prolactin on milk synthesis.

Human chorionic gonadotropin (hCG) is secreted by the syncitiotrophoblast and can be detected within nine days of pregnancy. It mimics LH, rescuing the corpus luteum from degenerating and ensuring early oestrogen and progesterone secretion. It also stimulates the production of relaxin and may inhibit contractions induced by oxytocin. Other hormones produced during pregnancy include relaxin, which suppresses myometrial contractions and relaxes the pelvic ligaments and pubic symphysis, and human placental lactogen (hPL), which has lactogenic actions and enhances protein metabolism while antagonizing insulin.

During pregnancy, the development of carbohydrate intolerance is referred to as gestational diabetes mellitus. To diagnose this condition, an OGTT is typically performed at 28 weeks, although it may be done earlier for those at higher risk (such as those of Asian or Afro-Caribbean ethnicity, with a BMI over 30, a history of stillbirth, or family members with diabetes). Diabetes during pregnancy can increase the likelihood of various complications, including macrosomia, polyhydramnios, shoulder dystocia, congenital heart defects, neural tube defects, and neonatal hypoglycemia. Ebstein’s anomaly of the heart can occur as a result of lithium use during pregnancy, while prolonged rupture of membranes during pregnancy can lead to neonatal infection.

Gestational diabetes is a common medical disorder that affects around 4% of pregnancies. It can develop during pregnancy or be a pre-existing condition. According to NICE, 87.5% of cases are gestational diabetes, 7.5% are type 1 diabetes, and 5% are type 2 diabetes. Risk factors for gestational diabetes include a BMI of > 30 kg/m², previous gestational diabetes, a family history of diabetes, and family origin with a high prevalence of diabetes. Screening for gestational diabetes involves an oral glucose tolerance test (OGTT), which should be performed as soon as possible after booking and at 24-28 weeks if the first test is normal.

To diagnose gestational diabetes, NICE recommends using the following thresholds: fasting glucose is >= 5.6 mmol/L or 2-hour glucose is >= 7.8 mmol/L. Newly diagnosed women should be seen in a joint diabetes and antenatal clinic within a week and taught about self-monitoring of blood glucose. Advice about diet and exercise should be given, and if glucose targets are not met within 1-2 weeks of altering diet/exercise, metformin should be started. If glucose targets are still not met, insulin should be added to the treatment plan.

For women with pre-existing diabetes, weight loss is recommended for those with a BMI of > 27 kg/m^2. Oral hypoglycaemic agents, apart from metformin, should be stopped, and insulin should be commenced. Folic acid 5 mg/day should be taken from pre-conception to 12 weeks gestation, and a detailed anomaly scan at 20 weeks, including four-chamber view of the heart and outflow tracts, should be performed. Tight glycaemic control reduces complication rates, and retinopathy should be treated as it can worsen during pregnancy.

Targets for self-monitoring of pregnant women with diabetes include a fasting glucose level of 5.3 mmol/l and a 1-hour or 2-hour glucose level after meals of 7.8 mmol/l or 6.4 mmol/l, respectively. It is important to manage gestational diabetes and pre-existing diabetes during pregnancy to reduce the risk of complications for both the mother and baby.

Hyperemesis gravidarum (HG) is a condition characterized by persistent vomiting, dehydration, weight loss, and electrolyte imbalance, often accompanied by ketosis. Women with multiple pregnancies are at an increased risk of developing HG due to the higher concentrations of pregnancy-related hormones.

Other risk factors for HG include trophoblastic disease, molar pregnancy, and a history of previous hyperemesis. Hypertension of pregnancy typically occurs after 16 weeks and is not associated with an increased risk of HG.

Large for gestational age is not a risk factor for HG as it is usually diagnosed later in pregnancy during growth scans. Multiparity alone is not a risk factor, but a history of previous hyperemesis or nausea and vomiting during pregnancy increases the risk.

Hyperemesis gravidarum is a severe form of nausea and vomiting that affects around 1% of pregnancies. It is usually experienced between 8 and 12 weeks of pregnancy but can persist up to 20 weeks. The condition is thought to be related to raised beta hCG levels and is more common in women who are obese, nulliparous, or have multiple pregnancies, trophoblastic disease, or hyperthyroidism. Smoking is associated with a decreased incidence of hyperemesis.

The Royal College of Obstetricians and Gynaecologists recommend that a woman must have a 5% pre-pregnancy weight loss, dehydration, and electrolyte imbalance before a diagnosis of hyperemesis gravidarum can be made. Validated scoring systems such as the Pregnancy-Unique Quantification of Emesis (PUQE) score can be used to classify the severity of NVP.

Management of hyperemesis gravidarum involves using antihistamines as a first-line treatment, with oral cyclizine or oral promethazine being recommended by Clinical Knowledge Summaries. Oral prochlorperazine is an alternative, while ondansetron and metoclopramide may be used as second-line treatments. Ginger and P6 (wrist) acupressure can be tried, but there is little evidence of benefit. Admission may be needed for IV hydration.

Complications of hyperemesis gravidarum can include Wernicke’s encephalopathy, Mallory-Weiss tear, central pontine myelinolysis, acute tubular necrosis, and fetal growth restriction, pre-term birth, and cleft lip/palate (if ondansetron is used during the first trimester). The NICE Clinical Knowledge Summaries recommend considering admission if a woman is unable to keep down liquids or oral antiemetics, has ketonuria and/or weight loss (greater than 5% of body weight), or has a confirmed or suspected comorbidity that may be adversely affected by nausea and vomiting.

Breastfeeding has been linked to prolonged neonatal jaundice, which is characterized by high levels of bilirubin in an otherwise healthy breastfed newborn after the first week of life. This type of jaundice lasts longer than normal and has no other identifiable cause. It is important to consider the age at which jaundice appears in order to determine potential underlying causes, such as haemolytic disease, infections, G6PD deficiency, sepsis, polycythaemia, extrahepatic biliary atresia, congenital hypothyroidism, or breastfeeding.

Advantages and Disadvantages of Breastfeeding

Breastfeeding has numerous advantages for both the mother and the baby. For the mother, it promotes bonding with the baby and helps with the involution of the uterus. It also provides protection against breast and ovarian cancer and is a cheap alternative to formula feeding as there is no need to sterilize bottles. However, it should not be relied upon as a contraceptive method as it is unreliable.

Breast milk contains immunological components such as IgA, lysozyme, and lactoferrin that protect mucosal surfaces, have bacteriolytic properties, and ensure rapid absorption of iron so it is not available to bacteria. This reduces the incidence of ear, chest, and gastrointestinal infections, as well as eczema, asthma, and type 1 diabetes mellitus. Breastfeeding also reduces the incidence of sudden infant death syndrome.

One of the advantages of breastfeeding is that the baby is in control of how much milk it takes. However, there are also disadvantages such as the transmission of drugs and infections such as HIV. Prolonged breastfeeding may also lead to nutrient inadequacies such as vitamin D and vitamin K deficiencies, as well as breast milk jaundice.

In conclusion, while breastfeeding has numerous advantages, it is important to be aware of the potential disadvantages and to consult with a healthcare professional to ensure that both the mother and the baby are receiving adequate nutrition and care.

During pregnancy, the main contributor to the increased cardiac output is the increased stroke volume, which is caused by the activation of the renin-angiotensin system and the subsequent increase in plasma volume. Although the heart rate also increases slightly, it is not as significant as the increase in stroke volume. Therefore, the major contributor to the increased cardiac output is the stroke volume.

The statements ‘decreased heart rate’ and ‘increased peripheral resistance’ are incorrect. In fact, peripheral resistance decreases due to progesterone, which contributes to the normal decrease in blood pressure during pregnancy. Peripheral resistance is more concerned with blood pressure.

Pregnancy also causes various physiological changes, including increased uterine size, cervical ectropion, reduced cervical collagen, and increased vaginal discharge. Cardiovascular and haemodynamic changes include increased plasma volume, anaemia, increased white cell count, platelets, ESR, cholesterol, and fibrinogen, as well as decreased albumin, urea, and creatinine. Progesterone-related effects, such as muscle relaxation, can cause decreased blood pressure, constipation, ureteral dilation, bladder relaxation, biliary stasis, and increased tidal volume.

During pregnancy, a woman’s body undergoes various physiological changes. The cardiovascular system experiences an increase in stroke volume, heart rate, and cardiac output, while systolic blood pressure remains unchanged and diastolic blood pressure decreases in the first and second trimesters before returning to normal levels by term. The enlarged uterus may cause issues with venous return, leading to ankle swelling, supine hypotension, and varicose veins.

The respiratory system sees an increase in pulmonary ventilation and tidal volume, with oxygen requirements only increasing by 20%. This can lead to a sense of dyspnea due to over-breathing and a fall in pCO2. The basal metabolic rate also increases, potentially due to increased thyroxine and adrenocortical hormones.

Maternal blood volume increases by 30%, with red blood cells increasing by 20% and plasma increasing by 50%, leading to a decrease in hemoglobin levels. Coagulant activity increases slightly, while fibrinolytic activity decreases. Platelet count falls, and white blood cell count and erythrocyte sedimentation rate rise.

The urinary system experiences an increase in blood flow and glomerular filtration rate, with elevated sex steroid levels leading to increased salt and water reabsorption and urinary protein losses. Trace glycosuria may also occur.

Calcium requirements increase during pregnancy, with gut absorption increasing substantially due to increased 1,25 dihydroxy vitamin D. Serum levels of calcium and phosphate may fall, but ionized calcium levels remain stable. The liver experiences an increase in alkaline phosphatase and a decrease in albumin levels.

The uterus undergoes significant changes, increasing in weight from 100g to 1100g and transitioning from hyperplasia to hypertrophy. Cervical ectropion and discharge may increase, and Braxton-Hicks contractions may occur in late pregnancy. Retroversion may lead to retention in the first trimester but usually self-corrects.

The ovarian cycle consists of three main stages: the follicular phase (day 1-10), the ovulatory phase (day 11-14), and the luteal phase (day 15-28). During the follicular phase, follicle stimulating hormone (FSH) and luteinising hormone (LH) stimulate the growth of 10-20 follicles, from which one oocyte is selected while the others become atretic. The mature follicle releases oestrogen, which stimulates the renewal and thickening of the uterine lining. In the ovulatory phase, the mature follicle (2 cm) ruptures and exits. Finally, during the luteal phase, the oocyte travels through the uterine tubule while the remaining follicular cells develop into the corpus luteum. As the ovaries age, the number of available and viable ovarian follicles decreases, resulting in a reduced response to FSH and LH.

Understanding Menopause and Contraception

Menopause is a natural biological process that marks the end of a woman’s reproductive years. It typically occurs when a woman reaches the age of 51 in the UK. However, prior to menopause, women may experience a period known as the climacteric. During this time, ovarian function starts to decline, and women may experience symptoms such as hot flashes, mood swings, and vaginal dryness.

It is important for women to understand that they can still become pregnant during the climacteric period. Therefore, it is recommended to use effective contraception until a certain period of time has passed. Women over the age of 50 should use contraception for 12 months after their last period, while women under the age of 50 should use contraception for 24 months after their last period. By understanding menopause and the importance of contraception during the climacteric period, women can make informed decisions about their reproductive health.

The cessation of oestradiol and progesterone production in the ovaries, which can be caused naturally or by medical intervention, leads to menopause. This decrease in hormone production often results in elevated levels of FSH and LH.

Understanding Menopause and Contraception

Menopause is a natural biological process that marks the end of a woman’s reproductive years. It typically occurs when a woman reaches the age of 51 in the UK. However, prior to menopause, women may experience a period known as the climacteric. During this time, ovarian function starts to decline, and women may experience symptoms such as hot flashes, mood swings, and vaginal dryness.

It is important for women to understand that they can still become pregnant during the climacteric period. Therefore, it is recommended to use effective contraception until a certain period of time has passed. Women over the age of 50 should use contraception for 12 months after their last period, while women under the age of 50 should use contraception for 24 months after their last period. By understanding menopause and the importance of contraception during the climacteric period, women can make informed decisions about their reproductive health.

Macrosomia is a significant risk factor for neonatal brachial plexus injuries resulting from shoulder dystocia. Maternal diabetes mellitus, not diabetes insipidus, is the leading cause of macrosomia, which is often associated with a high BMI. While polyhydramnios may result from foetal insulin resistance due to maternal diabetes mellitus, it is not a specific risk factor for brachial plexus injuries as there are many other causes of polyhydramnios. A family history of preeclampsia is not relevant to this condition.

Shoulder dystocia is a complication that can occur during vaginal delivery when the body of the fetus cannot be delivered after the head has already been delivered. This is usually due to the anterior shoulder of the fetus becoming stuck on the mother’s pubic bone. Shoulder dystocia can cause harm to both the mother and the baby.

There are several risk factors that increase the likelihood of shoulder dystocia, including fetal macrosomia (large baby), high maternal body mass index, diabetes mellitus, and prolonged labor.

If shoulder dystocia is identified, it is important to call for senior medical assistance immediately. The McRoberts’ maneuver is often used to help deliver the baby. This involves flexing and abducting the mother’s hips to increase the angle of the pelvis and facilitate delivery. An episiotomy may be performed to provide better access for internal maneuvers, but it will not relieve the bony obstruction. Symphysiotomy and the Zavanelli maneuver are not recommended as they can cause significant harm to the mother. Oxytocin administration is not effective in treating shoulder dystocia.

Complications of shoulder dystocia can include postpartum hemorrhage and perineal tears for the mother, and brachial plexus injury or neonatal death for the baby. It is important to manage shoulder dystocia promptly and effectively to minimize these risks.

Monozygotic twins with one chorion and two amnions are the result of division between days 4 and 8 after fertilization. This type of twinning has diamniotic, monochorionic placentation. Division between days 8 and 12 after fertilization leads to monozygotic twins with monoamniotic, monochorionic placentation, while fertilization of two separate eggs with two separate sperm results in dizygotic twins with diamniotic, dichorionic placentation. It’s important to note that division between days 4 and 8 after fertilization does not result in dizygotic twins.

Twin Pregnancies: Incidence, Types, and Complications

Twin pregnancies occur in approximately 1 out of 105 pregnancies, with the majority being dizygotic or non-identical twins. Monozygotic or identical twins, on the other hand, develop from a single ovum that has divided to form two embryos. However, monoamniotic monozygotic twins are associated with increased risks of spontaneous miscarriage, perinatal mortality rate, malformations, intrauterine growth restriction, prematurity, and twin-to-twin transfusions. The incidence of dizygotic twins is increasing due to infertility treatment, and predisposing factors include previous twins, family history, increasing maternal age, multigravida, induced ovulation, in-vitro fertilisation, and race, particularly Afro-Caribbean.

Antenatal complications of twin pregnancies include polyhydramnios, pregnancy-induced hypertension, anaemia, and antepartum haemorrhage. Fetal complications include perinatal mortality, prematurity, light-for-date babies, and malformations, especially in monozygotic twins. Labour complications may also arise, such as postpartum haemorrhage, malpresentation, cord prolapse, and entanglement.

Management of twin pregnancies involves rest, ultrasound for diagnosis and monthly checks, additional iron and folate, more antenatal care, and precautions during labour, such as having two obstetricians present. Most twins deliver by 38 weeks, and if longer, most are induced at 38-40 weeks. Overall, twin pregnancies require close monitoring and management to ensure the best possible outcomes for both mother and babies.

Ulipristal is classified as a selective progesterone receptor modulator, which is utilized for emergency contraception. It is recommended to be taken within 120 hours of unprotected intercourse, and its primary mode of action is believed to be the inhibition of ovulation.

Selective estrogen receptor modulators are employed in the treatment of breast cancer, osteoporosis, and postmenopausal symptoms.

Progesterone analogs activate receptors in a manner that closely resembles progesterone itself, and are typically included in hormonal contraceptive preparations.

Similarly, estrogen analogs imitate natural estrogen and are commonly found in hormonal contraceptives.

The mechanism of action for levonorgestrel, another frequently used emergency contraceptive, is currently unknown.

Emergency contraception is available in the UK through two methods: emergency hormonal contraception and intrauterine device (IUD). Emergency hormonal contraception includes two types of pills: levonorgestrel and ulipristal. Levonorgestrel works by stopping ovulation and inhibiting implantation, and should be taken as soon as possible after unprotected sexual intercourse (UPSI) for maximum efficacy. The single dose of levonorgestrel is 1.5 mg, but should be doubled for those with a BMI over 26 or weight over 70kg. It is safe and well-tolerated, but may cause vomiting in around 1% of women. Ulipristal, on the other hand, is a selective progesterone receptor modulator that inhibits ovulation. It should be taken within 120 hours after intercourse, and may reduce the effectiveness of hormonal contraception. The most effective method of emergency contraception is the copper IUD, which may inhibit fertilization or implantation. It must be inserted within 5 days of UPSI, or up to 5 days after the likely ovulation date. Prophylactic antibiotics may be given if the patient is at high-risk of sexually transmitted infection. The IUD is 99% effective regardless of where it is used in the cycle, and may be left in-situ for long-term contraception.

The correct answer is an increase in tidal volume and pulmonary ventilation. Pregnancy leads to an increase in tidal volume without any change in respiratory rate, resulting in an overall increase in pulmonary ventilation. This can cause respiratory alkalosis due to the loss of carbon dioxide.

Incorrect options include a decrease in tidal volume and an increase in pulmonary ventilation, which is not observed during pregnancy. Similarly, an increase in tidal volume and a decrease in pulmonary ventilation, or no change in either tidal volume or pulmonary ventilation, are also not accurate descriptions of respiratory changes during pregnancy.

During pregnancy, a woman’s body undergoes various physiological changes. The cardiovascular system experiences an increase in stroke volume, heart rate, and cardiac output, while systolic blood pressure remains unchanged and diastolic blood pressure decreases in the first and second trimesters before returning to normal levels by term. The enlarged uterus may cause issues with venous return, leading to ankle swelling, supine hypotension, and varicose veins.

The respiratory system sees an increase in pulmonary ventilation and tidal volume, with oxygen requirements only increasing by 20%. This can lead to a sense of dyspnea due to over-breathing and a fall in pCO2. The basal metabolic rate also increases, potentially due to increased thyroxine and adrenocortical hormones.

Maternal blood volume increases by 30%, with red blood cells increasing by 20% and plasma increasing by 50%, leading to a decrease in hemoglobin levels. Coagulant activity increases slightly, while fibrinolytic activity decreases. Platelet count falls, and white blood cell count and erythrocyte sedimentation rate rise.

The urinary system experiences an increase in blood flow and glomerular filtration rate, with elevated sex steroid levels leading to increased salt and water reabsorption and urinary protein losses. Trace glycosuria may also occur.

Calcium requirements increase during pregnancy, with gut absorption increasing substantially due to increased 1,25 dihydroxy vitamin D. Serum levels of calcium and phosphate may fall, but ionized calcium levels remain stable. The liver experiences an increase in alkaline phosphatase and a decrease in albumin levels.

The uterus undergoes significant changes, increasing in weight from 100g to 1100g and transitioning from hyperplasia to hypertrophy. Cervical ectropion and discharge may increase, and Braxton-Hicks contractions may occur in late pregnancy. Retroversion may lead to retention in the first trimester but usually self-corrects.

Anatomy of the Scrotum and Testes

The scrotum is composed of skin and dartos fascia, with an arterial supply from the anterior and posterior scrotal arteries. It is also the site of lymphatic drainage to the inguinal lymph nodes. The testes are surrounded by the tunica vaginalis, a closed peritoneal sac, with the parietal layer adjacent to the internal spermatic fascia. The testicular arteries arise from the aorta, just below the renal arteries, and the pampiniform plexus drains into the testicular veins. The left testicular vein drains into the left renal vein, while the right testicular vein drains into the inferior vena cava. Lymphatic drainage occurs to the para-aortic nodes.

The spermatic cord is formed by the vas deferens and is covered by the internal spermatic fascia, cremasteric fascia, and external spermatic fascia. The cord contains the vas deferens, testicular artery, artery of vas deferens, cremasteric artery, pampiniform plexus, sympathetic nerve fibers, genital branch of the genitofemoral nerve, and lymphatic vessels. The vas deferens transmits sperm and accessory gland secretions, while the testicular artery supplies the testis and epididymis. The cremasteric artery arises from the inferior epigastric artery, and the pampiniform plexus is a venous plexus that drains into the right or left testicular vein. The sympathetic nerve fibers lie on the arteries, while the parasympathetic fibers lie on the vas. The genital branch of the genitofemoral nerve supplies the cremaster. Lymphatic vessels drain to lumbar and para-aortic nodes.

Upper right quadrant pain can be caused by various conditions, but in this case, the woman is suffering from pelvic inflammatory disease, which is often associated with Fitz-Hugh-Curtis syndrome (adhesions of liver to peritoneum).

It is important to note that cholecystitis, pulmonary embolisms, pleurisy, and viral hepatitis do not typically present with symptoms such as dyspareunia, dysuria, or vaginal discharge.

Pelvic inflammatory disease (PID) is a condition where the female pelvic organs, including the uterus, fallopian tubes, ovaries, and surrounding peritoneum, become infected and inflamed. It is typically caused by an infection that spreads from the endocervix. The most common causative organism is Chlamydia trachomatis, followed by Neisseria gonorrhoeae, Mycoplasma genitalium, and Mycoplasma hominis. Symptoms of PID include lower abdominal pain, fever, dyspareunia, dysuria, menstrual irregularities, vaginal or cervical discharge, and cervical excitation.

To diagnose PID, a pregnancy test should be done to rule out an ectopic pregnancy, and a high vaginal swab should be taken to screen for Chlamydia and gonorrhoeae. However, these tests may often be negative, so consensus guidelines recommend having a low threshold for treatment due to the potential complications of untreated PID. Management typically involves oral ofloxacin and oral metronidazole or intramuscular ceftriaxone, oral doxycycline, and oral metronidazole. In mild cases of PID, intrauterine contraceptive devices may be left in, but the evidence is limited, and removal of the IUD may be associated with better short-term clinical outcomes according to recent guidelines.

Complications of PID include perihepatitis (Fitz-Hugh Curtis Syndrome), which occurs in around 10% of cases and is characterized by right upper quadrant pain that may be confused with cholecystitis, infertility (with a risk as high as 10-20% after a single episode), chronic pelvic pain, and ectopic pregnancy.

The most uncommon and recent occurrence of twins is when they are conjoined, resulting in a unique cleavage.

When twins share the same placenta, known as monochorionic twins, there is a possibility of uneven blood flow between them. This can lead to one twin receiving more blood than the other, which often requires medical intervention.

Dizygotic twins, which come from two separate eggs, have a higher chance of occurring in certain situations. These include being between the ages of 35-40, having a family history of twins, previously giving birth to multiples, having a high BMI, smoking, and conceiving in the summer or autumn.

Around 1 in 10 dichorionic twins are monozygotic, meaning they come from a single fertilized egg that splits into two embryos.

Triplets can occur when two eggs are fertilized, and one of them splits into a pair of monozygotic twins.

Twin Pregnancies: Incidence, Types, and Complications

Twin pregnancies occur in approximately 1 out of 105 pregnancies, with the majority being dizygotic or non-identical twins. Monozygotic or identical twins, on the other hand, develop from a single ovum that has divided to form two embryos. However, monoamniotic monozygotic twins are associated with increased risks of spontaneous miscarriage, perinatal mortality rate, malformations, intrauterine growth restriction, prematurity, and twin-to-twin transfusions. The incidence of dizygotic twins is increasing due to infertility treatment, and predisposing factors include previous twins, family history, increasing maternal age, multigravida, induced ovulation, in-vitro fertilisation, and race, particularly Afro-Caribbean.

Antenatal complications of twin pregnancies include polyhydramnios, pregnancy-induced hypertension, anaemia, and antepartum haemorrhage. Fetal complications include perinatal mortality, prematurity, light-for-date babies, and malformations, especially in monozygotic twins. Labour complications may also arise, such as postpartum haemorrhage, malpresentation, cord prolapse, and entanglement.

Management of twin pregnancies involves rest, ultrasound for diagnosis and monthly checks, additional iron and folate, more antenatal care, and precautions during labour, such as having two obstetricians present. Most twins deliver by 38 weeks, and if longer, most are induced at 38-40 weeks. Overall, twin pregnancies require close monitoring and management to ensure the best possible outcomes for both mother and babies.

During pregnancy, a woman’s body undergoes various physiological changes. The cardiovascular system experiences an increase in stroke volume, heart rate, and cardiac output, while systolic blood pressure remains unchanged and diastolic blood pressure decreases in the first and second trimesters before returning to normal levels by term. The enlarged uterus may cause issues with venous return, leading to ankle swelling, supine hypotension, and varicose veins.

The respiratory system sees an increase in pulmonary ventilation and tidal volume, with oxygen requirements only increasing by 20%. This can lead to a sense of dyspnea due to over-breathing and a fall in pCO2. The basal metabolic rate also increases, potentially due to increased thyroxine and adrenocortical hormones.

Maternal blood volume increases by 30%, with red blood cells increasing by 20% and plasma increasing by 50%, leading to a decrease in hemoglobin levels. Coagulant activity increases slightly, while fibrinolytic activity decreases. Platelet count falls, and white blood cell count and erythrocyte sedimentation rate rise.

The urinary system experiences an increase in blood flow and glomerular filtration rate, with elevated sex steroid levels leading to increased salt and water reabsorption and urinary protein losses. Trace glycosuria may also occur.

Calcium requirements increase during pregnancy, with gut absorption increasing substantially due to increased 1,25 dihydroxy vitamin D. Serum levels of calcium and phosphate may fall, but ionized calcium levels remain stable. The liver experiences an increase in alkaline phosphatase and a decrease in albumin levels.

The uterus undergoes significant changes, increasing in weight from 100g to 1100g and transitioning from hyperplasia to hypertrophy. Cervical ectropion and discharge may increase, and Braxton-Hicks contractions may occur in late pregnancy. Retroversion may lead to retention in the first trimester but usually self-corrects.

A haemoglobin level of 105 g/L is considered normal at 28 weeks of pregnancy, with the non-pregnant reference range being 115-165 g/L.

During pregnancy, a woman’s body undergoes various physiological changes. The cardiovascular system experiences an increase in stroke volume, heart rate, and cardiac output, while systolic blood pressure remains unchanged and diastolic blood pressure decreases in the first and second trimesters before returning to normal levels by term. The enlarged uterus may cause issues with venous return, leading to ankle swelling, supine hypotension, and varicose veins.

The respiratory system sees an increase in pulmonary ventilation and tidal volume, with oxygen requirements only increasing by 20%. This can lead to a sense of dyspnea due to over-breathing and a fall in pCO2. The basal metabolic rate also increases, potentially due to increased thyroxine and adrenocortical hormones.

Maternal blood volume increases by 30%, with red blood cells increasing by 20% and plasma increasing by 50%, leading to a decrease in hemoglobin levels. Coagulant activity increases slightly, while fibrinolytic activity decreases. Platelet count falls, and white blood cell count and erythrocyte sedimentation rate rise.

The urinary system experiences an increase in blood flow and glomerular filtration rate, with elevated sex steroid levels leading to increased salt and water reabsorption and urinary protein losses. Trace glycosuria may also occur.

Calcium requirements increase during pregnancy, with gut absorption increasing substantially due to increased 1,25 dihydroxy vitamin D. Serum levels of calcium and phosphate may fall, but ionized calcium levels remain stable. The liver experiences an increase in alkaline phosphatase and a decrease in albumin levels.

The uterus undergoes significant changes, increasing in weight from 100g to 1100g and transitioning from hyperplasia to hypertrophy. Cervical ectropion and discharge may increase, and Braxton-Hicks contractions may occur in late pregnancy. Retroversion may lead to retention in the first trimester but usually self-corrects.